MAM
PBYI icon

Meeder Asset Management’s Puma Biotechnology PBYI Stock Holding History

Meeder Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,078
Closed -$6K – 2363
2022
Q1 		$6K Buy
+2,078
New +$5.38K ﹤0.01% 1740
2021
Q4 		– Sell
-11,457
Closed -$81K – 2000
2021
Q3 		$81K Buy
11,457
+422
+4% +$3.16K ﹤0.01% 953
2021
Q2 		$101K Buy
+11,035
New +$112K ﹤0.01% 906
2020
Q4 		– Sell
-585
Closed -$5K – 2125
2020
Q3 		$5K Sell
585
-944
-62% -$9.61K ﹤0.01% 1581
2020
Q2 		$15K Buy
1,529
+600
+65% +$6.21K ﹤0.01% 1210
2020
Q1 		$8K Sell
929
-4,029
-81% -$39.1K ﹤0.01% 1623
2019
Q4 		$43K Buy
4,958
+3,119
+170% +$25.8K ﹤0.01% 1069
2019
Q3 		$20K Buy
1,839
+1,155
+169% +$12.5K ﹤0.01% 1313
2019
Q2 		$9K Buy
684
+581
+564% +$13.4K ﹤0.01% 1495
2019
Q1 		$4K Sell
103
-37
-26% -$1.13K ﹤0.01% 1450
2018
Q4 		$3K Buy
140
+16
+13% +$480 ﹤0.01% 1520
2018
Q3 		$6K Buy
124
+47
+61% +$2.27K ﹤0.01% 1298
2018
Q2 		$4.55K Buy
+77
New +$4.46K ﹤0.01% 1297
2018
Q1 		– Sell
-366
Closed -$37K – 1699
2017
Q4 		$37K Buy
366
+278
+316% +$31.1K ﹤0.01% 760
2017
Q3 		$11K Sell
88
-11
-11% -$1.02K ﹤0.01% 1064
2017
Q2 		$9K Sell
99
-82
-45% -$4.59K ﹤0.01% 1025
2017
Q1 		$7K Sell
181
-323
-64% -$11.8K ﹤0.01% 960
2016
Q4 		$15K Buy
+504
New +$21.8K ﹤0.01% 691

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Meeder Asset Management's PBYI Position: Q2 2022 in Review

Meeder Asset Management sold out of Puma Biotechnology (PBYI) in Q2 2022, closing a stake of 2,078 shares — an estimated $6K sold.

Meeder Asset Management first reported a position in PBYI in Q4 2016 and held it in 18 quarters. The position peaked at $101K in Q2 2021. 88 funds tracked by Wall St. Rank hold PBYI as of Q2 2022.

  • Meeder Asset Management reported no remaining Puma Biotechnology position as of Q2 2022 after selling out during the quarter.
  • Meeder Asset Management sold 2,078 Puma Biotechnology shares in Q2 2022, an estimated $6K.
  • Meeder Asset Management first reported a position in Puma Biotechnology in Q4 2016 and held it in 18 quarters.
  • Meeder Asset Management's Puma Biotechnology position peaked at $101K in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2022.

Based on Meeder Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.